Prevalence, Antimicrobial Susceptibility Pattern, and Associated Factors of Urinary Tract Infections among Pregnant and Nonpregnant Women at Public Health Facilities, Harar, Eastern Ethiopia: A Comparative Cross-Sectional Study

Table 3

Antimicrobial susceptibility pattern of Gram-negative bacteria isolated from the urine of pregnant and nonpregnant women at public health facilities, Harar, Eastern Ethiopia, from February 2017 to December 2017.

Bacteria isolates	n (%)	Pattern	Antimicrobial susceptibility testing, n (%)
			AML	CAZ	FOX	CRO	CIP	CN	STX
E. coli	42 (42)	S	7 (16.7)	39 (92.9)	35 (83.3)	18 (42.9)	7 (16.7)	34 (81)	8 (19)
		I	0 (0)	0 (0)	4 (9.5)	0 (0)	1 (2.4)	1 (2.4)	1 (2.4)
		R	35 (83.3)	3 (7.1)	3 (7.1)	24 (57.1)	34 (81)	7 (16.7)	33 (78.6)
Enterobacter spp.	11 (11)	S	3 (27.3)	10 (90.9)	6 (54.5)	11 (100)	1 (9.1)	10 (90.9)	7 (63.6)
		I	0 (0)	0 (0)	4 (36.4)	0 (0)	0 (0)	0 (0)	0 (0)
		R	8 (72.7)	1 (9.1)	1 (9.1)	0 (0)	10 (90.9)	1 (9.1)	4 (36.4)
Acinetobacter spp.	5 (5)	S	2 (40)	5 (100)	5 (100)	1 (20)	4 (80)	5 (100)	1 (20)
		I	1 (20)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
		R	2 (40)	0 (0)	0 (0)	4 (80)	1 (20)	0 (0)	4 (80)
Klebsiella spp.	15 (15)	S	2 (13.3)	11 (73.3)	9 (60)	10 (66.7)	14 (93.3)	8 (53.3)	3 (20)
		I	0 (0)	0 (0)	1 (6.7)	0 (0)	1 (6.7)	1 (6.7)	1 (6.7)
		R	13 (86.7)	4 (26.7)	5 (33.3)	5 (32.3)	0 (0)	6 (40)	11 (73.3)
P. aeruginosa	11 (11)	S	2 (18.2)	10 (90.9)	9 (81.8)	5 (45)	9 (81.8)	4 (36.4)	1 (9.1)
		I	0 (0)	1 (9.1)	1 (9.1)	0 (0)	0 (0)	0 (0)	0 (0)
		R	9 (81.8)	0 (0)	1 (9.1)	6 (54.5)	2 (18.2)	7 (63.6)	11 (90.9)
Proteus spp.	16 (16)	S	13 (81.3)	16 (100)	15 (93.8)	14 (87.5)	1 (6.2)	5 (31.2)	7 (43.3)
		I	0 (0)	0 (0)	1 (6.3)	0 (0)	1 (6.2)	6 (37.6)	0 (0)
		R	3 (18.8)	0 (0)	0 (0)	2 (12.5)	14 (87.5)	5 (31.2)	9 (56.2)
Total, n (%)	100	S	29 (29)	91 (91)	79 (79)	59 (59)	36 (36)	66 (66)	27 (27)
		I	1 (1)	1 (1)	11 (11)	0 (0)	3 (3)	8 (8)	3 (3)
		R	70 (60)	8 (8)	10 (10)	41 (41)	61 (61)	26 (26)	70 (70)

S: sensitive; I: intermediate; R: resistance; AML: amoxicillin; CAZ: ceftazidime; FOX: cefoxitin; CIP: ciprofloxacin; CN: gentamicin; CRO: ceftriaxone; STX: trimethoprim-sulfamethoxazole.